← Eichor
Condition: Bile Duct Diseases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Bile Duct Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Phase 3 · 42 location(s) · Cascade Pharmaceuticals, Inc · NCT07282353Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic C
NA · 8 location(s) · Aichi Medical University · NCT07235007QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing
NA · 2 location(s) · Anna Evans Phillips · NCT03434392Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06864481Association of Intrahepatic Cholestasis of Pregnancy and Chronic Placental Inflammation
Phase N/A · 11 location(s) · University Hospital, Brest · NCT05197387Fenofibrate in Primary Biliary Cholangitis: a Real World Study
Phase 3 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT06755151Application of Machine Learning Models to Reduce Need for Diagnostic EUS or MRCP in Patients With Intermediate Likelihoo
Phase N/A · 1 location(s) · Asian Institute of Gastroenterology, India · NCT06066372EUS Procedures Using RIVOS™ EUS Access Device
Phase N/A · 1 location(s) · Orlando Health, Inc. · NCT07696572A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · 186 location(s) · Ipsen · NCT06016842Influence of Gut Microbiome in Gallstone Disease
Phase N/A · 1 location(s) · East Kent Hospitals University NHS Foundation Trust · NCT05732480Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT06825559Laparoendoscopic Rendezvous for Concomitant Gall Bladder Stones and Common Bile Duct Stones
NA · 1 location(s) · Minia University · NCT07008170The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
Phase N/A · 1 location(s) · Samsung Medical Center · NCT03637569Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06519162Biochemical Response and Clinical Outcomes in Patients With PBC
Phase N/A · 1 location(s) · RenJi Hospital · NCT07449793The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasi
EARLY_Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT07250854Laser vs Electrohydraulic Lithotripsy for Difficult CBD Stones
NA · 2 location(s) · Mahidol University · NCT07030829Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · 205 location(s) · Gilead Sciences · NCT06051617A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)
Phase 1 · 1 location(s) · Takeda · NCT07229911Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
Phase N/A · 1 location(s) · Children's Hospital of Fudan University · NCT05848310Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study
Phase N/A · 1 location(s) · Oslo University Hospital · NCT07449897A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahe
Phase N/A · 1 location(s) · Takeda · NCT07293897Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia
NA · 1 location(s) · National Liver Institute, Egypt · NCT06708572Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
Phase 2 · 1 location(s) · Mayo Clinic · NCT06905054RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis
NA · 1 location(s) · Hospital Clinic of Barcelona · NCT07161245Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Phase 1/Phase 2 · 11 location(s) · Genfit · NCT05874414Intravital Microscopy in Human Solid Tumors
NA · 1 location(s) · Mayo Clinic · NCT03823144The Treatment Effect for Asymptomatic Common Bile Duct Stone
Phase N/A · 1 location(s) · Kyungpook National University Hospital · NCT06215040Efficacy and Safety of Surgical Treatment for Type IVa CBD
Phase N/A · 1 location(s) · Beijing Tsinghua Chang Gung Hospital · NCT07036848Primary Sclerosing Cholangitis in Children
Phase N/A · 12 location(s) · Arbor Research Collaborative for Health · NCT04181138
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.